| Literature DB >> 34741801 |
Suresh Kumar1, Ruheena Javed1, Michal Mudd1, Sandeep Pallikkuth2, Keith A Lidke2, Ashish Jain3, Karthikeyan Tangavelou1, Sigurdur Runar Gudmundsson4, Chunyan Ye5, Tor Erik Rusten3, Jan Haug Anonsen6, Alf Håkon Lystad3, Aurore Claude-Taupin1, Anne Simonsen3, Michelle Salemi7, Brett Phinney7, Jing Li8, Lian-Wang Guo8, Steven B Bradfute5, Graham S Timmins9, Eeva-Liisa Eskelinen10, Vojo Deretic11.
Abstract
The biogenesis of mammalian autophagosomes remains to be fully defined. Here, we used cellular and in vitro membrane fusion analyses to show that autophagosomes are formed from a hitherto unappreciated hybrid membrane compartment. The autophagic precursors emerge through fusion of FIP200 vesicles, derived from the cis-Golgi, with endosomally derived ATG16L1 membranes to generate a hybrid pre-autophagosomal structure, HyPAS. A previously unrecognized apparatus defined here controls HyPAS biogenesis and mammalian autophagosomal precursor membranes. HyPAS can be modulated by pharmacological agents whereas its formation is inhibited upon severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or by expression of SARS-CoV-2 nsp6. These findings reveal the origin of mammalian autophagosomal membranes, which emerge via convergence of secretory and endosomal pathways, and show that this process is targeted by microbial factors such as coronaviral membrane-modulating proteins.Entities:
Keywords: ATG16L1; Atg8ylation; COVID-19; FIP200; Golgi; SARS-CoV-2; Syntaxin 17; autophagy; coronavirus; endosome
Mesh:
Substances:
Year: 2021 PMID: 34741801 PMCID: PMC8616855 DOI: 10.1016/j.cell.2021.10.017
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582